Research & Innovation
Publications
Potential to improve the therapeutic situation of HCC patients - The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC.
PMU Authors
Maximilian Alexander Ardelt, Petra Huber-Cantonati, Johanna Pachmayr
All Authors
Maximilian Alexander Ardelt, Petra Huber-Cantonati, Johanna Pachmayr
Abstract
We are sorry. The full text is not available.